Haoqiang Ying, Ph.D. - Publications

Affiliations: 
2007 Boston University, Boston, MA, United States 
Area:
Molecular Biology, Biochemistry

90 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Yuan M, Tu B, Li H, Pang H, Zhang N, Fan M, Bai J, Wang W, Shu Z, DuFort CC, Huo S, Zhai J, Yao K, Wang L, Ying H, et al. Cancer-associated fibroblasts employ NUFIP1-dependent autophagy to secrete nucleosides and support pancreatic tumor growth. Nature Cancer. PMID 35982178 DOI: 10.1038/s43018-022-00426-6  0.344
2022 Kerk S, Lin L, Myers AL, Sutton DJ, Andren A, Sajjakulnukit P, Zhang L, Zhang Y, Jiménez JA, Nelson BS, Chen B, Robinson A, Thurston G, Kemp SB, Steele NG, ... ... Ying H, et al. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context. Elife. 11. PMID 35815941 DOI: 10.7554/eLife.73245  0.345
2022 Liu Y, Deguchi Y, Wei D, Liu F, Moussalli MJ, Deguchi E, Li D, Wang H, Valentin LA, Colby JK, Wang J, Zheng X, Ying H, Gagea M, Ji B, et al. Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ. Nature Communications. 13: 2665. PMID 35562376 DOI: 10.1038/s41467-022-30392-7  0.315
2021 Kim PK, Halbrook CJ, Kerk SA, Radyk M, Wisner S, Kremer DM, Sajjakulnukit P, Andren A, Hou SW, Trivedi A, Thurston G, Anand A, Yan L, Salamanca-Cardona L, Welling SD, ... ... Ying H, et al. Hyaluronic acid fuels pancreatic cancer cell growth. Elife. 10. PMID 34951587 DOI: 10.7554/eLife.62645  0.347
2021 Deng Y, Xia X, Zhao Y, Zhao Z, Martinez C, Yin W, Yao J, Hang Q, Wu W, Zhang J, Yu Y, Xia W, Yao F, Zhao D, Sun Y, ... Ying H, et al. Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance. Nature Communications. 12: 7041. PMID 34873175 DOI: 10.1038/s41467-021-27349-7  0.308
2021 Yan H, Yu CC, Fine SA, Youssof AL, Yang YR, Yan J, Karg DC, Cheung EC, Friedman RA, Ying H, Chen EI, Luo J, Miao Y, Qiu W, Su GH. Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. Oncogene. PMID 34663879 DOI: 10.1038/s41388-021-02040-9  0.393
2021 Giuliani V, Miller MA, Liu CY, Hartono SR, Class CA, Bristow CA, Suzuki E, Sanz LA, Gao G, Gay JP, Feng N, Rose JL, Tomihara H, Daniele JR, Peoples MD, ... ... Ying H, et al. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma. Nature Communications. 12: 4626. PMID 34330913 DOI: 10.1038/s41467-021-24798-y  0.317
2021 Yan L, Tu B, Yao J, Gong J, Carugo A, Bristow CA, Wang Q, Zhu C, Dai B, Kang Y, Han L, Feng N, Jin Y, Fleming J, Heffernan TP, ... ... Ying H, et al. Targeting glucose metabolism sensitizes pancreatic cancer to MEK inhibition. Cancer Research. PMID 34117030 DOI: 10.1158/0008-5472.CAN-20-3792  0.368
2021 Chang WH, Thi Nguyen TT, Hsu CH, Bryant KL, Kim HJ, Ying H, Erickson JW, Der CJ, Cerione RA, Antonyak MA. KRAS-dependent cancer cells promote survival by producing exosomes enriched in Survivin. Cancer Letters. PMID 34111513 DOI: 10.1016/j.canlet.2021.05.031  0.334
2021 Oh H, Hwang I, Jang JY, Wu L, Cao D, Yao J, Ying H, Li JY, Yao Y, Hu B, Wang Q, Zheng H, Paik J. Therapy-induced transdifferentiation promotes glioma growth independent of EGFR signaling. Cancer Research. PMID 33509942 DOI: 10.1158/0008-5472.CAN-20-1810  0.52
2020 Maitituoheti M, Keung EZ, Tang M, Yan L, Alam H, Han G, Singh AK, Raman AT, Terranova C, Sarkar S, Orouji E, Amin SB, Sharma S, Williams M, Samant NS, ... ... Ying H, et al. Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma. Cell Reports. 33: 108293. PMID 33086062 DOI: 10.1016/j.celrep.2020.108293  0.345
2020 Bryant KL, Stalnecker CA, Zeitouni D, Klomp JE, Peng S, Tikunov AP, Gunda V, Pierobon M, Waters AM, George SD, Tomar G, Papke B, Hobbs GA, Yan L, Hayes TK, ... ... Ying H, et al. Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nature Medicine. PMID 32483362 DOI: 10.1038/S41591-020-0947-8  0.339
2020 Yao W, Maitra A, Ying H. Recent insights into the biology of pancreatic cancer. Ebiomedicine. 102655. PMID 32139179 DOI: 10.1016/J.Ebiom.2020.102655  0.367
2020 Dey P, Li J, Zhang J, Chaurasiya S, Strom A, Wang H, Liao WT, Cavallaro F, Denz P, Bernard V, Yen EY, Genovese G, Gulhati P, Liu J, Chakravarti D, ... ... Ying H, et al. Oncogenic Kras driven metabolic reprogramming in pancreas cancer cells utilizes cytokines from the tumor microenvironment. Cancer Discovery. PMID 32046984 DOI: 10.1158/2159-8290.Cd-19-0297  0.423
2020 Wang G, Lu X, Chakravarti D, Kapoor A, Yao W, Ying H, Dey P, Wu C, Spring D, Hou P, Deng P, Zhao D, Hu B, Xizeng M, Logothesis C, et al. Abstract IA24: YAP in cancer and inflammation Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Hippo19-Ia24  0.4
2020 Boutin A, Chen P, Dey P, Hou P, Liao W, Lu X, Ying H, Zhao D, DePinho RA. Abstract IA01: Modeling and understanding tumor biologic mechanisms Cancer Research. 80. DOI: 10.1158/1538-7445.Camodels2020-Ia01  0.448
2019 Kapoor A, Yao W, Ying H, Hua S, Liewen A, Wang Q, Zhong Y, Wu CJ, Sadanandam A, Hu B, Chang Q, Chu GC, Al-Khalil R, Jiang S, Xia H, et al. Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer. Cell. 179: 1239. PMID 31730860 DOI: 10.1016/J.Cell.2019.10.037  0.378
2019 Yan L, Raj P, Yao W, Ying H. Glucose Metabolism in Pancreatic Cancer. Cancers. 11. PMID 31569510 DOI: 10.3390/Cancers11101460  0.432
2019 Tu B, Yao J, Ferri-Borgogno S, Zhao J, Chen S, Wang Q, Yan L, Zhou X, Zhu C, Bang S, Chang Q, Bristow CA, Kang Y, Zheng H, Wang H, ... ... Ying H, et al. YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma. Jci Insight. PMID 31557131 DOI: 10.1172/Jci.Insight.130811  0.625
2019 Li F, Deng Z, Zhang L, Wu C, Jin Y, Hwang I, Vladimirova O, Xu L, Yang L, Lu B, Dheekollu J, Li JY, Feng H, Hu J, Vakoc CR, ... Ying H, et al. ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization. The Embo Journal. e96659. PMID 31454099 DOI: 10.15252/Embj.201796659  0.561
2019 Yu M, Nguyen ND, Huang Y, Lin D, Fujimoto TN, Molkentine JM, Deorukhkar A, Kang Y, San Lucas FA, Fernandes CJ, Koay EJ, Gupta S, Ying H, Koong AC, Herman JM, et al. Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. Jci Insight. 5. PMID 31335325 DOI: 10.1172/Jci.Insight.126915  0.363
2019 Yao W, Rose JL, Wang W, Seth S, Jiang H, Taguchi A, Liu J, Yan L, Kapoor A, Hou P, Chen Z, Wang Q, Nezi L, Xu Z, Yao J, ... ... Ying H, et al. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. PMID 30918400 DOI: 10.1038/S41586-019-1062-1  0.433
2019 Bryant KL, Stalnecker CA, Zeitouni D, Klomp JE, Peng S, Tikunov AP, Gunda V, Pierobon M, Waters AM, George SD, Tomar G, Papke B, Hobbs GA, Yan L, Hayes TK, ... ... Ying H, et al. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nature Medicine. PMID 30833752 DOI: 10.1038/S41591-019-0368-8  0.405
2019 Chen Z, Liu J, Ho I, Rose J, Yan L, Yao W, Viale A, Carugo A, Ying H, Draetta G. Abstract C12: Lipids signaling contributes to glucose-independent metabolic adaptation in pancreatic ductal adenocarcinoma Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-C12  0.4
2018 Santana-Codina N, Roeth AA, Zhang Y, Yang A, Mashadova O, Asara JM, Wang X, Bronson RT, Lyssiotis CA, Ying H, Kimmelman AC. Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. Nature Communications. 9: 4945. PMID 30470748 DOI: 10.1038/S41467-018-07472-8  0.439
2018 Xing Z, Zhang Y, Liang K, Yan L, Xiang Y, Li C, Hu Q, Jin F, Putluri V, Putluri N, Coarfa C, Sreekumar A, Park PK, Nguyen TK, Wang S, ... ... Ying H, et al. Expression of long non-coding RNA YIYA promotes glycolysis in breast cancer. Cancer Research. PMID 29967256 DOI: 10.1158/0008-5472.Can-17-0385  0.426
2018 Wang YN, Lee HH, Chou CK, Yang WH, Wei Y, Chen CT, Yao J, Hsu JL, Zhu C, Ying H, Ye Y, Wang WJ, Lim SO, Xia W, Ko HW, et al. Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer. Cancer Cell. PMID 29606349 DOI: 10.1016/J.Ccell.2018.02.012  0.313
2018 Zhao N, Cao J, Xu L, Tang Q, Dobrolecki LE, Lv X, Talukdar M, Lu Y, Wang X, Hu DZ, Shi Q, Xiang Y, Wang Y, Liu X, Bu W, ... ... Ying H, et al. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. The Journal of Clinical Investigation. PMID 29480818 DOI: 10.1172/Jci95873  0.504
2018 Dey P, Baddour J, Kim Y, Macloed R, Muller F, Wu CC, Wang H, Viale A, Ying H, Draetta G, Maitra A, Wang A, Nagrath D, DePinho R. Abstract 777: Malic enzyme 3 as a collateral lethality target in pancreatic cancer Cancer Research. 78: 777-777. DOI: 10.1158/1538-7445.Am2018-777  0.469
2017 Ju HQ, Ying H, Tian T, Ling J, Fu J, Lu Y, Wu M, Yang L, Achreja A, Chen G, Zhuang Z, Wang H, Nagrath D, Yao J, Hung MC, et al. Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma. Nature Communications. 8: 14437. PMID 28232723 DOI: 10.1038/Ncomms14437  0.408
2017 Genovese G, Carugo A, Tepper J, Robinson FS, Li L, Svelto M, Nezi L, Corti D, Minelli R, Pettazzoni P, Gutschner T, Wu CC, Seth S, Akdemir KC, Leo E, ... ... Ying H, et al. Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. Nature. PMID 28178232 DOI: 10.1038/Nature21064  0.451
2017 Dey P, Baddour J, Muller F, Wu CC, Wang H, Liao WT, Lan Z, Chen A, Gutschner T, Kang Y, Fleming J, Satani N, Zhao D, Achreja A, Yang L, ... ... Ying H, et al. Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. Nature. PMID 28099419 DOI: 10.1038/Nature21052  0.373
2016 Mann KM, Ying H, Juan J, Jenkins NA, Copeland NG. KRAS-related proteins in pancreatic cancer. Pharmacology & Therapeutics. PMID 27595930 DOI: 10.1016/J.Pharmthera.2016.09.003  0.33
2016 Sousa CM, Biancur DE, Wang X, Halbrook CJ, Sherman MH, Zhang L, Kremer D, Hwang RF, Witkiewicz AK, Ying H, Asara JM, Evans RM, Cantley LC, Lyssiotis CA, Kimmelman AC. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature. PMID 27509858 DOI: 10.1038/Nature19084  0.373
2016 Jiang X, Niu M, Chen D, Chen J, Cao Y, Li X, Ying H, Bergholz J, Zhang Y, Xiao ZX. Inhibition of Cdc42 is essential for Mig-6 suppression of cell migration induced by EGF. Oncotarget. PMID 27341132 DOI: 10.18632/Oncotarget.10205  0.431
2016 Ying H, Dey P, Yao W, Kimmelman AC, Draetta GF, Maitra A, DePinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes & Development. 30: 355-85. PMID 26883357 DOI: 10.1101/Gad.275776.115  0.33
2016 Tsang YH, Dogruluk T, Tedeschi PM, Wardwell-Ozgo J, Lu H, Espitia M, Nair N, Minelli R, Chong Z, Chen F, Chang QE, Dennison JB, Dogruluk A, Li M, Ying H, et al. Functional annotation of rare gene aberration drivers of pancreatic cancer. Nature Communications. 7: 10500. PMID 26806015 DOI: 10.1038/Ncomms10500  0.45
2015 Klingler S, Guo B, Yao J, Yan H, Zhang L, Vaseva AV, Chen S, Canoll P, Horner JW, Wang YA, Paik JH, Ying H, Zheng H. Development of Resistance to EGFR-Targeted Therapy in Malignant Glioma Can Occur through EGFR-Dependent and -Independent Mechanisms. Cancer Research. 75: 2109-19. PMID 25808866 DOI: 10.1158/0008-5472.Can-14-3122  0.516
2015 Pettazzoni P, Viale A, Shah P, Carugo A, Ying H, Wang H, Genovese G, Seth S, Minelli R, Green T, Huang-Hobbs E, Corti D, Sanchez N, Nezi L, Marchesini M, et al. Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer. Cancer Research. 75: 1091-101. PMID 25736685 DOI: 10.1158/0008-5472.Can-14-1854  0.424
2015 Tong Y, Ying H, Liu R, Li L, Bergholz J, Xiao ZX. Pin1 inhibits PP2A-mediated Rb dephosphorylation in regulation of cell cycle and S-phase DNA damage. Cell Death & Disease. 6: e1640. PMID 25675300 DOI: 10.1038/Cddis.2015.3  0.427
2015 Viale A, Pettazzoni P, Lyssiotis C, Ying H, Sánchez N, Marchesini M, Carugo A, Green T, Seth S, Giuliani V, Heffernan T, Kimmelman A, Wang H, Fleming J, Cantley L, et al. Abstract PR13: Pancreatic tumor stem cells resistant to inhibition of oncogenic signaling are dependent on mitochondrial function Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-Pr13  0.465
2015 Lyssiotis CA, Son J, Mancias JD, Ying H, Cantley LC, Kimmelman AC. Abstract B45: Pancreatic cancers depend on a non-canonical glutamine metabolism pathway Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-B45  0.423
2015 Kapoor A, Yao W, Ying H, Hua S, Liewen A, Sadanandam A, Al-Khalil R, Viale A, Pettazzoni P, Sanchez N, Protopopov A, Zhang J, Heffernan T, Johnson RL, Chin L, et al. Abstract A94: Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A94  0.494
2015 Yao W, Wang W, Taguchi A, Kapoor A, Momin A, Jiang H, Rose J, Celiktas M, Deem A, Hanash S, DePinho R, Ying H, Draetta G. Abstract A18: Syndecan-1 is required for oncogenic Kras-driven PDAC tumorigenesis and maintenance Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A18  0.478
2015 Yao W, Ying H, Draetta G. Abstract C157: Syndecan1 is required for oncogenic Kras-driven PDAC tumorigenesis and maintenance Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C157  0.485
2014 Viale A, Pettazzoni P, Lyssiotis CA, Ying H, Sánchez N, Marchesini M, Carugo A, Green T, Seth S, Giuliani V, Kost-Alimova M, Muller F, Colla S, Nezi L, Genovese G, et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature. 514: 628-32. PMID 25119024 DOI: 10.1038/Nature13611  0.424
2014 Ying H, DePinho RA. Cancer signaling: when phosphorylation meets methylation. Cell Research. 24: 1282-3. PMID 25104733 DOI: 10.1038/Cr.2014.103  0.38
2014 Kapoor A, Yao W, Ying H, Hua S, Liewen A, Wang Q, Zhong Y, Wu CJ, Sadanandam A, Hu B, Chang Q, Chu GC, Al-Khalil R, Jiang S, Xia H, et al. Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell. 158: 185-97. PMID 24954535 DOI: 10.1016/J.Cell.2014.06.003  0.48
2014 Stopczynski RE, Normolle DP, Hartman DJ, Ying H, DeBerry JJ, Bielefeldt K, Rhim AD, DePinho RA, Albers KM, Davis BM. Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma. Cancer Research. 74: 1718-27. PMID 24448244 DOI: 10.1158/0008-5472.Can-13-2050  0.345
2014 Lyssiotis C, Son J, Mancias J, Ying H, Kimmelman A, Cantley L. Pancreatic cancers depend on a non-canonical glutamine metabolism pathway Cancer & Metabolism. 2. DOI: 10.1186/2049-3002-2-S1-P44  0.434
2014 Taguchi A, Kapoor A, Momin A, Katayama H, Yao W, Wang H, Ying H, DePinho R, Hanash S. Abstract PR03: Global quantitative proteomic and phosphoproteomic analysis of oncogenic Kras-driven mouse pancreatic cancer Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Rasonc14-Pr03  0.443
2014 Kapoor A, Yao W, Ying H, Hua S, Liewen A, Wang Q, Zhong Y, Wu C, Sadanandam A, Hu B, Chang Q, Chu G, Al-Khalil R, Jiang S, Xia H, et al. Abstract PR01: Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Rasonc14-Pr01  0.49
2014 Taguchi A, Kapoor A, Momin A, Katayama H, Yao W, Wang H, Ying H, DePinho R, Hanash S. Tu1678 Global Quantitative Proteomic and Phosphoproteomic Analysis of Oncogenic Kras-Driven Mouse Pancreatic Cancer Gastroenterology. 146: S-816. DOI: 10.1016/S0016-5085(14)62954-1  0.365
2013 Jun S, Lee S, Kim HC, Ng C, Schneider AM, Ji H, Ying H, Wang H, DePinho RA, Park JI. PAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis. Cell Reports. 5: 314-22. PMID 24209743 DOI: 10.1016/J.Celrep.2013.09.026  0.445
2013 Yeo H, Lyssiotis CA, Zhang Y, Ying H, Asara JM, Cantley LC, Paik JH. FoxO3 coordinates metabolic pathways to maintain redox balance in neural stem cells. The Embo Journal. 32: 2589-602. PMID 24013118 DOI: 10.1038/Emboj.2013.186  0.324
2013 Zhang Y, Shin SJ, Liu D, Ivanova E, Foerster F, Ying H, Zheng H, Xiao Y, Chen Z, Protopopov A, Depinho RA, Paik JH. ZNF365 promotes stability of fragile sites and telomeres. Cancer Discovery. 3: 798-811. PMID 23776040 DOI: 10.1158/2159-8290.Cd-12-0536  0.597
2013 Du W, Yi Y, Zhang H, Bergholz J, Wu J, Ying H, Zhang Y, Xiao ZX. Rapamycin inhibits IGF-1-mediated up-regulation of MDM2 and sensitizes cancer cells to chemotherapy. Plos One. 8: e63179. PMID 23638184 DOI: 10.1371/Journal.Pone.0063179  0.502
2013 Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, Perera RM, Ferrone CR, Mullarky E, Shyh-Chang N, Kang Y, Fleming JB, Bardeesy N, Asara JM, Haigis MC, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 496: 101-5. PMID 23535601 DOI: 10.1038/Nature12040  0.416
2013 Du W, Yi Y, Zhang H, Bergholz J, Wu J, Ying H, Zhang Y, Xiao ZJ. Correction: Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy Plos One. 8. DOI: 10.1371/annotation/f1a4d192-57b9-43fb-a248-379e0f5a46ca  0.715
2013 Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, Perera RM, Ferrone CR, Mullarky E, Shyh-Chang N, Kang Y, Fleming JB, Bardeesy N, Asara JM, Haigis MC, et al. Erratum: Corrigendum: Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway Nature. 499: 504-504. DOI: 10.1038/Nature12317  0.399
2012 Chen AJ, Paik JH, Zhang H, Shukla SA, Mortensen R, Hu J, Ying H, Hu B, Hurt J, Farny N, Dong C, Xiao Y, Wang YA, Silver PA, Chin L, et al. STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA. Genes & Development. 26: 1459-72. PMID 22751500 DOI: 10.1101/Gad.189001.112  0.423
2012 Genovese G, Ergun A, Shukla SA, Campos B, Hanna J, Ghosh P, Quayle SN, Rai K, Colla S, Ying H, Wu CJ, Sarkar S, Xiao Y, Zhang J, Zhang H, et al. microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma. Cancer Discovery. 2: 736-49. PMID 22750848 DOI: 10.1158/2159-8290.Cd-12-0111  0.497
2012 Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC, Fletcher-Sananikone E, Locasale JW, Son J, Zhang H, Coloff JL, Yan H, Wang W, Chen S, Viale A, Zheng H, et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell. 149: 656-70. PMID 22541435 DOI: 10.1016/J.Cell.2012.01.058  0.612
2012 Hu J, Hwang SS, Liesa M, Gan B, Sahin E, Jaskelioff M, Ding Z, Ying H, Boutin AT, Zhang H, Johnson S, Ivanova E, Kost-Alimova M, Protopopov A, Wang YA, et al. Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell. 148: 651-63. PMID 22341440 DOI: 10.1016/J.Cell.2011.12.028  0.431
2012 Tai Y, Landesman Y, Acharya C, Zhong MY, Calle Y, Cea M, Hu Y, Cagnetta A, Tannenbaum D, Chen M, Munshi A, Senapedis W, Saint-Martin J, Kashyap T, Ying H, et al. CRM1 Blockade by Novel Inhibitors of Nuclear Export (SINEs) Inhibits Multiple Myeloma Cell Growth, Osteoclastogenesis, and Myeloma-Induced Osteolysis Blood. 120: 326-326. DOI: 10.1182/Blood.V120.21.326.326  0.302
2012 Stopczynski RE, Albers KM, Bielefeldt K, DePinho RA, Ying H, Davis BM. Abstract PR4: Neuroplastic changes and pain-related behavior in a transgenic mouse model of pancreatic ductal adenocarcinoma (PDAC). Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-Pr4  0.334
2012 Son J, Lyssiotis CA, Yang S, Ying H, Wang X, Cantley LC, Kimmelman AC. Abstract IA14: Autophagy, metabolism, and pancreatic cancer. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-Ia14  0.426
2012 Lyssiotis C, Ying H, Kimmelman A, DePinho R, Cantley L. Abstract A51: Oncogenic Kras is required for pancreatic tumor maintenance through the regulation of anabolic glucose metabolism. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A51  0.447
2012 Ying H, Zhang H, Coloff JL, Yan H, Wang W, Chen S, Viale A, Zheng H, Paik J, Lim C, Guimaraes AR, Kimmelman AC, Martin ES, Chang J, Hezel A, et al. Abstract A101: Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A101  0.619
2012 Chen S, Johnson N, Auger KR, Xiao Y, Ying H, Marszalek J, Middleton R, Andersen JN, McGrath JP, Chin L. Abstract 3714: Characterization of a selective focal adhesion kinase (FAK) inhibitor in a panel of glioblastoma cell lines identify rational drug-drug combination strategies Cancer Research. 72: 3714-3714. DOI: 10.1158/1538-7445.Am2012-3714  0.408
2011 Ying H, Elpek KG, Vinjamoori A, Zimmerman SM, Chu GC, Yan H, Fletcher-Sananikone E, Zhang H, Liu Y, Wang W, Ren X, Zheng H, Kimmelman AC, Paik JH, Lim C, et al. PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network. Cancer Discovery. 1: 158-69. PMID 21984975 DOI: 10.1158/2159-8290.Cd-11-0031  0.618
2011 Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, Bause A, Li Y, Stommel JM, Dell'antonio G, Mautner J, Tonon G, Haigis M, Shirihai OS, Doglioni C, et al. Pancreatic cancers require autophagy for tumor growth. Genes & Development. 25: 717-29. PMID 21406549 DOI: 10.1101/Gad.2016111  0.469
2010 Zheng H, Ying H, Wiedemeyer R, Yan H, Quayle SN, Ivanova EV, Paik JH, Zhang H, Xiao Y, Perry SR, Hu J, Vinjamoori A, Gan B, Sahin E, Chheda MG, et al. PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell. 17: 497-509. PMID 20478531 DOI: 10.1016/J.Ccr.2010.03.020  0.581
2010 Ying H, Zheng H, Scott K, Wiedemeyer R, Yan H, Lim C, Huang J, Dhakal S, Ivanova E, Xiao Y, Zhang H, Hu J, Stommel JM, Lee MA, Chen AJ, et al. Mig-6 controls EGFR trafficking and suppresses gliomagenesis. Proceedings of the National Academy of Sciences of the United States of America. 107: 6912-7. PMID 20351267 DOI: 10.1073/Pnas.0914930107  0.599
2010 Stopczynski RE, DePinho RA, Ying H, Schwartz ES, Albers KM, Davis BM, Bielefeldt K. 412 Neuroplastic Changes in a Mouse Model of Pancreatic Ductal Adenocarcinoma (PDAC) Gastroenterology. 138: S-62. DOI: 10.1016/S0016-5085(10)60280-6  0.393
2009 Paik JH, Ding Z, Narurkar R, Ramkissoon S, Muller F, Kamoun WS, Chae SS, Zheng H, Ying H, Mahoney J, Hiller D, Jiang S, Protopopov A, Wong WH, Chin L, et al. FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis. Cell Stem Cell. 5: 540-53. PMID 19896444 DOI: 10.1016/J.Stem.2009.09.013  0.568
2009 Mineva ND, Wang X, Yang S, Ying H, Xiao ZX, Holick MF, Sonenshein GE. Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation. Journal of Cellular Physiology. 220: 593-9. PMID 19373868 DOI: 10.1002/Jcp.21765  0.373
2008 Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z, Stommel JM, Dunn KL, Wiedemeyer R, You MJ, Brennan C, et al. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. Cold Spring Harbor Symposia On Quantitative Biology. 73: 427-37. PMID 19150964 DOI: 10.1101/Sqb.2008.73.047  0.633
2008 Kimmelman AC, Hezel AF, Aguirre AJ, Zheng H, Paik JH, Ying H, Chu GC, Zhang JX, Sahin E, Yeo G, Ponugoti A, Nabioullin R, Deroo S, Yang S, Wang X, et al. Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proceedings of the National Academy of Sciences of the United States of America. 105: 19372-7. PMID 19050074 DOI: 10.1073/Pnas.0809966105  0.594
2008 Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z, Stommel JM, Dunn KL, Wiedemeyer R, You MJ, Brennan C, et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature. 455: 1129-33. PMID 18948956 DOI: 10.1038/Nature07443  0.606
2007 Stommel JM, Kimmelman AC, Ying H, Nabioullin R, Ponugoti AH, Wiedemeyer R, Stegh AH, Bradner JE, Ligon KL, Brennan C, Chin L, DePinho RA. Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science (New York, N.Y.). 318: 287-90. PMID 17872411 DOI: 10.1126/Science.1142946  0.4
2007 Chang DL, Qiu W, Ying H, Zhang Y, Chen CY, Xiao ZX. ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2. Oncogene. 26: 4627-34. PMID 17297463 DOI: 10.1038/Sj.Onc.1210254  0.731
2006 Ying H, Xiao ZX. Targeting retinoblastoma protein for degradation by proteasomes. Cell Cycle (Georgetown, Tex.). 5: 506-8. PMID 16552188 DOI: 10.4161/Cc.5.5.2515  0.421
2005 Sdek P, Ying H, Chang DL, Qiu W, Zheng H, Touitou R, Allday MJ, Xiao ZX. MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Molecular Cell. 20: 699-708. PMID 16337594 DOI: 10.1016/J.Molcel.2005.10.017  0.758
2005 Currier N, Solomon SE, Demicco EG, Chang DL, Farago M, Ying H, Dominguez I, Sonenshein GE, Cardiff RD, Xiao ZX, Sherr DH, Seldin DC. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicologic Pathology. 33: 726-37. PMID 16263698 DOI: 10.1080/01926230500352226  0.714
2005 Ying H, Chang DL, Zheng H, McKeon F, Xiao ZX. DNA-binding and transactivation activities are essential for TAp63 protein degradation. Molecular and Cellular Biology. 25: 6154-64. PMID 15988026 DOI: 10.1128/Mcb.25.14.6154-6164.2005  0.729
2005 Murray SA, Yang S, Demicco E, Ying H, Sherr DH, Hafer LJ, Rogers AE, Sonenshein GE, Xiao ZX. Increased expression of MDM2, cyclin D1, and p27Kip1 in carcinogen-induced rat mammary tumors. Journal of Cellular Biochemistry. 95: 875-84. PMID 15844214 DOI: 10.1002/Jcb.20414  0.442
2004 Sdek P, Ying H, Zheng H, Margulis A, Tang X, Tian K, Xiao ZX. The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth. The Journal of Biological Chemistry. 279: 53317-22. PMID 15485814 DOI: 10.1074/Jbc.M406062200  0.653
2003 Gu L, Ying H, Zheng H, Murray SA, Xiao ZX. The MDM2 RING finger is required for cell cycle-dependent regulation of its protein expression. Febs Letters. 544: 218-22. PMID 12782320 DOI: 10.1016/S0014-5793(03)00502-7  0.687
2003 Gu L, Zheng H, Murray SA, Ying H, Jim Xiao ZX. Deregulation of Cdc2 kinase induces caspase-3 activation and apoptosis. Biochemical and Biophysical Research Communications. 302: 384-91. PMID 12604359 DOI: 10.1016/S0006-291X(03)00189-X  0.642
Show low-probability matches.